BackgroundFor the context in which this post was created please go here and read the comments.
The Two Conflicting Papers - Huge Problems or Science in Progress?
1) The T-ve paper is based on 10 papers covering 1,131 trial subjects (they listed the papers and the number of subjects for each study). That's pretty impressive.2) The T+ve paper is based on 22 papers covering 3,428 trial subjects (they also listed the papers and the number of subjects for each study). That's even more impressive.And3) The far and away most interesting thing is that the sheer numbers pale in light of the fact that the larger set of studies (paper T+ve) includes every one of the 10 papers of the studies from the T-ve paper.
The Third Paper (Second Positive Result)
1 - just pre-print, but has been up since 15 FEB 2021 and has not been removed, presumably it is still out for review.2 - The study is not double blind, the participants either chose to take or not take the ivermectin. The size of two classes were sufficiently large to produce decent statistics (3532 total, 1147 no dose, 188 one dose, & 2197 two doses).3 - The study was only one month long and no extra treatments were applied if they became infected.